Global Dermal Filler Market 2017-2021
About Dermal Fillers
Dermal filler is an injectable drug used to diminish facial lines and restore volume and fullness in the face. It is used to plump thin lips, soften facial creases and wrinkles, enhance shallow contours, and improve the appearance of recessed scars. One of the aspects of modern life, which is considered as essential by men as well as women is appearance. The urge to look as good as they feel has led to the notable growth in the cosmetology industry.
Technavio’s analysts forecast the global dermal fillers market to grow at a CAGR of 7.01% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global dermal fillers market for 2017-2021. To calculate the market size, the report considers the revenue generated from the dermal filler products.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Dermal Fillers Market 2017-2021
Technavio recognizes the following companies as the key players in the global dermal fillers market: Allergan, Galderma, Merz Pharma, and Suneva Medical.
Other Prominent Vendors in the market are: Laboratoires VIVACY, Luminera Derm, Medytox, SciVision Biotech, Sinclair Pharma, TEOXANE, VisionMed, and VITAL ESTHETIQUE.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is emergence of combination treatments. The combination of various surgeries has become a new trend in the market. Surgeons have started adopting a combination of surgical and non-surgical procedures to provide more comprehensive results.”
According to the report, one driver in the market is shift from invasive to minimally invasive and non-invasive procedures. Minimally invasive and non-invasive procedures are the techniques that limit the size of incisions and therefore lessens pain and scarring, speedy recoveries, and reduces the incidence of post-surgical complications, such as adhesions and wound dehiscence. There has been an increase in the popularity of minimally invasive and non-invasive aesthetic procedures such as facial rejuvenation and liposuction.
Further, the report states that one challenge in the market is increase in warnings from the FDA. The FDA received more than 930 reports of adverse effects over the last decade from numerous approved dermal fillers. There have been many reports of severe and unexpected problems in people who were treated with dermal fillers. The inappropriate injection of dermal fillers can restrict blood supply to tissues and can block blood vessels in the face. This can sometimes lead to embolization, a common complication during facial aesthetic procedures.
Allergan, Galderma, Merz Pharma, Suneva Medical, Laboratoires VIVACY, Luminera Derm, Medytox, SciVision Biotech, Sinclair Pharma, TEOXANE, VisionMed, and VITAL ESTHETIQUE.